Filters

See more specimen types...

Other countries

Results: 1 to 17 of 17 (representing 10 labs)

Tests names and labsConditionsGenes and analytesMethods

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
6021038
  • C Sequence analysis of the entire coding region

MyPRS - Myeloma Prognostic Risk Signature

Myeloma Health Signal Genetics
United States
167
  • I Immunohistochemistry
  • R RNA analysis

Amyotrophic lateral sclerosis type 18

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Sequencing Panel

PreventionGenetics
United States
1721
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amyotrophic Lateral Sclerosis / Motor Neuron Disease via the PFN1 Gene

PreventionGenetics
United States
11
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Nonprevalent Amyotrophic Lateral Sclerosis Advanced Sequencing Evaluation

Athena Diagnostics Inc
United States
2415
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis Advanced Evaluation

Athena Diagnostics Inc
United States
1917
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amyotrophic Lateral Sclerosis

Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health and Science University
United States
1221
  • C Sequence analysis of the entire coding region

NGS panel - dementia

Genome Diagnostics VU University Medical Center
Netherlands
2341
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region
  • T Targeted variant analysis

Single gene testing PFN1

CeGaT GmbH
Germany
11
  • C Sequence analysis of the entire coding region

Amyotrophic lateral sclerosis 18 (sequence analysis of PFN1 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis (ALS) Panel

CeGaT GmbH
Germany
2954
  • C Sequence analysis of the entire coding region

Hereditary Spastic Paraplegias (HSP) and differential diagnoses Panel

CeGaT GmbH
Germany
147143
  • -- Sequence analysis of the entire coding region

PFN1

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis NGS Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
4724
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

ALS panel

Centogene AG - the Rare Disease Company
Germany
122
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

ALS

Neuromuscular Disorders Laboratory Northwestern University Feinberg School of Medicine
United States
113
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 17 of 17

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center